|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.81 USD | -0.42% |
|
-10.25% | +7.48% |
| 07-07 | Race to launch weight-loss pills heats up as smaller players advance | RE |
| 07-07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
Chart calendar Viking Therapeutics, Inc.
Upcoming events on Viking Therapeutics, Inc.
No events available
Past events on Viking Therapeutics, Inc.
| 19/05/2026 | Annual General Meeting | 16:00 |
| 19/05/2026 | Présentation aux Actionnaires / Analystes | 16:00 |
| 29/04/2026 | Earnings release - Q1 2026 | |
| 29/04/2026 | Earnings presentation | 21:30 |
| 11/02/2026 | Earnings release - Q4 2025 | |
| 11/02/2026 | Earnings presentation | 21:30 |
| 22/10/2025 | Earnings release - Q3 2025 | |
| 22/10/2025 | Earnings presentation | 21:30 |
| 19/08/2025 | Information meeting | 13:00 |
| 23/07/2025 | Earnings presentation | 21:30 |
| 23/07/2025 | Earnings release - Q2 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 141 |
|
EBITDA Million USD | Released Forecast Spread | -101 -100 -0.65% | -151 -142 -6.25% | -393 -324 -21.54% | -552 | -678 | -581 |
|
EBIT Million USD | Released Forecast Spread | -101 -99,5 -1.31% | -151 -143 -5.65% | -393 -335 -17.47% | -590 | -604 | -541 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -85,9 -86,9 1.11% | -110 -108 -1.83% | -360 -306 -17.4% | -565 | -589 | -519 |
|
Net income Million USD | Released Forecast Spread | -85,9 -86,6 0.85% | -110 -107 -2.43% | -360 -306 -17.64% | -563 | -587 | -499 |
|
EPS USD | Released Forecast Spread | -0,91 -0,92 1.52% | -1,01 -0,99 -2.15% | -3,19 -2,72 -17.2% | -4,81 | -4,63 | -3,84 |
| Announcement Date | 07/02/24 | 05/02/25 | 11/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -36,6 -34,4 -6.37% | -46,2 -38,8 -19.3% | -55,5 -46,3 -19.79% | -74,6 -54,4 -37.07% | -98,6 -90,3 -9.2% | -165 -105 -57.35% | -164 -130 -26.73% | -142 | -139 | -148 | |||||
|
EBIT Million USD | Released Forecast Spread | -36,6 -35,2 -3.76% | -46,2 -38,5 -20.05% | -55,5 -46,6 -19.03% | -74,6 -59,4 -25.59% | -98,6 -86,0 -14.55% | -165 -108 -53.07% | -164 -129 -27.53% | -149 | -140 | -138 | -140 | -142 | -144 | -146 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,9 -27,8 10.23% | -35,4 -30,6 -15.57% | -45,6 -40,0 -14% | -65,6 -52,1 -25.77% | -90,8 -79,4 -14.37% | -158 -103 -53.73% | -158 -116 -36.61% | -143 | -133 | -130 | -133 | -135 | -138 | -139 | |
|
Net income Million USD | Released Forecast Spread | -24,9 -27,6 9.74% | -35,4 -30,3 -16.75% | -45,6 -40,1 -13.87% | -65,6 -52,0 -26.05% | -90,8 -78,7 -15.29% | -158 -102 -54.22% | -158 -114 -39.06% | -144 | -131 | -129 | -133 | -135 | -138 | -139 | |
|
EPS USD | Released Forecast Spread | -0,22 -0,25 11.55% | -0,32 -0,27 -16.71% | -0,41 -0,35 -17.66% | -0,58 -0,46 -25.93% | -0,81 -0,70 -15.99% | -1,38 -0,91 -52.18% | -1,37 -1,00 -37.66% | -1,24 | -1,11 | -1,09 | -0,96 | -0,94 | -0,93 | -0,92 | |
| Announcement Date | 23/10/24 | 05/02/25 | 23/04/25 | 23/07/25 | 22/10/25 | 11/02/26 | 29/04/26 | - | - | - | - | - | - | - | - |
| 23/07/2026 |  | Earnings release - Q2 2026 | |
| 24/07/2026 | | Earnings release - Q2 2026 | |
| 27/07/2026 | | Information meeting | 13:00 |
| 29/07/2026 | | Sales and Revenue Release - Q2 2026 | *E4DFANSWAPTOBAIJ22ORFMMWNCSDVOFTFBPAR |
| 30/07/2026 | | Extraordinary General Meeting | 07:30 |
| 30/07/2026 | | Earnings presentation | 13:00 |
| 30/07/2026 | | Earnings release - Q2 2026 | |
| 30/07/2026 | | Earnings release - Q2 2026 | |
| 30/07/2026 | | Earnings presentation | 13:00 |
| 30/07/2026 | | Extraordinary General Meeting | 01:30 |
Past sector events for Viking Therapeutics, Inc.
| Today | | Extraordinary General Meeting | 01:01 |
| 14/07/2026 | | Information meeting | 22:30 |
| 14/07/2026 | | Présentation aux Actionnaires / Analystes | 05:00 |
| 09/07/2026 | | Significant Split/Dividend | 05:00 |
| 09/07/2026 | | Ex-dividend date - 1.49015 TWD | 05:00 |
| 09/07/2026 | | Earnings presentation | 07:00 |
| 09/07/2026 | | Information meeting | 13:30 |
| 08/07/2026 | | Analyst/Investor Day | 01:01 |
| 07/07/2026 | | Earnings presentation | 07:30 |
| 07/07/2026 | | Earnings presentation | 05:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VKTX Stock
- Calendar Viking Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition